Fig. 5From: Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8IL-8 level in PTX- and CpdA-treated BCA cells. Protein levels of IL-8 measured by ELISA in (a) MDA-MB-231 and (b) MDA-MB-435 cells after either 25 nM PTX or 12.5 μM CpdA treatments. Bars represent mean ± SD of independent duplicate experiments. *p-value < 0.05Back to article page